Pharmaceutical composition for treating bronchitis and asthma

Abstract

The invention relates to a pharmaceutical composition for treating bronchitis and asthma. The pharmaceutical composition is prepared from the following components by weight: 40 to 60 parts of aster root, 40 to 60 parts of dandelion, 25 to 35 parts of stemona root, 25 to 35 parts of anemarrhena, 20 to 30 parts of tendrilleaf fritillary bulb, 10 to 20 parts of ephedra stem, 10 to 20 parts of common andrographis herb, 10 to 20 parts of isatis root, 3 to 8 parts of LagotisclarkeiHook.F., 3 to 8 parts of borneol and 3 to 8 parts of dwarf lilyturf root. The ministerial drugs of the pharmaceutical composition are capable of clearing heat, removing toxins, eliminating phlegm, dissipating binds, generating body fluid and moisturizing dryness, thereby eliminating inflammations of bronchi and the lung, and capable of tonifying the spleen and the kidney, thereby eliminating the symptom of difficulty in breathing; the adjuvant and conductant drugs are used for maintenance and protection of the respiratory system and for basis consolidation; drugs of the pharmaceutical composition are compatible and synergistic, so inflammations are eliminated, and the adjuvant and conductant drugs are cooperatively used for alleviation of toxicity and virulence of drugs; and the pharmaceutical composition is used for treating a series of symptoms caused by bronchitis and asthma.

Description

technical field [0001] The invention relates to a medicine for common diseases in respiratory medicine, in particular to a medicine composition for treating bronchitis and asthma. Background technique [0002] Bronchial asthma, also commonly known as asthma. Clinical manifestations: The patient has difficulty breathing, shortness of breath, often accompanied by itching of the nasopharynx, dry cough, chest tightness, blue lips and purple face, opening the mouth and raising the shoulders, whimpering in the chest, sweating on the forehead, difficulty lying down, repeated attacks, lasting several minutes each time , a few hours or even a few days, mostly at night and in the early morning. Severe cases are accompanied by increased heart rate, abnormal pulse, abnormal movement of the chest and abdomen, and cyanosis. The etiology and pathogenesis of asthma are not completely clear, the treatment methods and drugs are different, and the curative effects are definite, especially th...

AI Technical Summary

Problems solved by technology

The etiology and pathogenesis of asthma are not completely clear, and the treatment methods and drugs are different, but the curative effect is definite, especially the drugs that can cure are still lacking

In recent years, foreign studies have used aminophylline and cetrol to treat bronchial asthma. The curative effect is better at the beginning, and then the patient's body becomes more resistant to western medicine. For this chronic disease that is often falsely accused, it is necessary to increase the dosage. In order to achieve the therapeutic effect, and some due to the drug resistance of patients, it is difficult to see the effect even if the dosage is increased. At the same time, these drugs have relatively large toxic and side effects and many complications, making it difficult for many weak patients who are often ill to take them. ; In addition, Western medicine usually treats the symptoms but not the root cause, and the duration of the drug effect is short

Clinically, there are also patients who take both Chinese and Western medicines, but there are still disadvantages of taking large doses and relatively poor effects